SCHEMBL30926

SCHEMBL30926

COC(C)OC1(C(N)=O)CCCCC1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19616 0.83 CYP2C19 (0.32)
Acetic Acid SCHEMBL20746004 0.80
SCHEMBL9568683 0.76 LMNA (0.40) LMNA
SCHEMBL2771351 0.73 LMNA (0.37) LMNA
SCHEMBL31337 0.70 LMNA (0.32) LMNA
SCHEMBL12605383 0.69
SCHEMBL15135616 0.69
SCHEMBL9790493 0.69 LMNA (0.33) LMNA
SCHEMBL16478350 0.67 LMNA (0.33) LMNA
SCHEMBL19135 0.67 LMNA (0.34) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2608669-A1 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS Merck Sharp & Dohme Corp. (US) 2013-07-03 EP disclosed
WO-2012027236-A1 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS SCHERING CORPORATION (US) 2012-03-01 WO disclosed